Amgen | Eiendeler

Assets Endring Dato
AbbVie USD 136.22B 854M 2023-09
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
ALKERMES USD 2.28B 92.05M 2023-09
Amgen USD 97.15B 6.62B 2023-12
Eli Lilly USD 57.92B 3.1B 2023-09
Exelixis USD 2.98B 165.56M 2023-09
Genmab DKK 35.24B 3.26B 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Incyte USD 6.78B 393.87M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Moderna USD 18.43B 1.02B 2023-12
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Takeda JPY 14.87T 79.15B 2023-09
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Amgen Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.